Drugmaker touts ‘major breakthrough’ with coronavirus inhaler treatment

British drugmaker Synairgen says it has developed a new coronavirus inhaler treatment that helps prevent hospitalized patients from getting seriously ill. The company announced results Monday from a small clinical trial of its drug known as SNG001 that it called a potential “major breakthrough” in the fight against the bug, even though the study reportedly… Continue reading at New York Post